NTHI
NASDAQ · Pharmaceuticals
Neonc Technologies Holdings
$4.06
-0.36 (-8.14%)
Open$4.42
Previous Close$4.42
Day High$4.47
Day Low$4.03
52W High$12.99
52W Low$3.20
Volume—
Avg Volume150.2K
Market Cap164.10M
P/E Ratio—
EPS$-3.20
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 84.9K | 67.4K | 45.52M |
| Net Income | -129,487,847 | -92,506,002 | 8.50M |
| Profit Margin | -155,404.4% | -147,634.2% | 18.7% |
| EBITDA | -122,636,745 | -92,478,891 | 13.90M |
| Free Cash Flow | — | — | 13.27M |
| Rev Growth | +26.0% | +26.0% | -1.4% |
| Debt/Equity | — | — | 0.08 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |